lobbying_activities: 1239041

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1239041	3fe24a08-4808-4735-be46-01bcbc054770	Q1	PODESTA GROUP, INC.	31680	MILLENNIUM PHARMACEUTICALS INC	2012	first_quarter	PHA	Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2012-04-19T16:00:14.237000-04:00